Cases & Deals

Galenica acquires Relypsa for $1.53 billion

Client(s) Galenica AG

Jones Day advised Galenica AG, a diversified group of companies active throughout the health care market, in its acquisition of Relypsa, Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of polymeric medicines, pursuant to a tender offer in which Galenica paid $32 per share, or a total of $1.53 billion.

In addition to M&A representation, Jones Day provided antitrust, employee benefits, and tax advice regarding this transaction.